Literature DB >> 19645087

Practice guidelines for acute bacterial meningitidis (except newborn and nosocomial meningitis).

.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19645087     DOI： 10.1016/j.medmal.2009.02.037

Source DB:  PubMed          Journal:  Med Mal Infect        ISSN： 0399-077X            Impact factor:   2.152


× No keyword cloud information.
  4 in total

1.  Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy.

Authors:  Jean-Pierre Quenot; Charles-Edouard Luyt; Nicolas Roche; Martin Chalumeau; Pierre-Emmanuel Charles; Yann-Eric Claessens; Sigismond Lasocki; Jean-Pierre Bedos; Yves Péan; François Philippart; Stéphanie Ruiz; Christele Gras-Leguen; Anne-Marie Dupuy; Jérôme Pugin; Jean-Paul Stahl; Benoit Misset; Rémy Gauzit; Christian Brun-Buisson
Journal:  Ann Intensive Care       Date:  2013-07-08       Impact factor: 6.925

2.  First initial community-acquired meningitis due to extended-spectrum beta-lactamase producing Escherichia coli complicated with multiple aortic mycotic aneurysms.

Authors:  Pierre Weyrich; Nicolas Ettahar; Laurence Legout; Agnes Meybeck; Olivier Leroy; Eric Senneville
Journal:  Ann Clin Microbiol Antimicrob       Date:  2012-02-09       Impact factor: 3.944

3.  In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes.

Authors:  J A Lepe; A Rodríguez-Villodres; G Martín-Gutiérrez; R Luque; J Aznar
Journal:  Rev Esp Quimioter       Date:  2019-09-12       Impact factor: 1.553

4.  Ceftriaxone therapy attenuates brain trauma in rats by affecting glutamate transporters and neuroinflammation and not by its antibacterial effects.

Authors:  Sher-Wei Lim; Hui-Chen Su; Tee-Tau Eric Nyam; Chung-Ching Chio; Jinn-Rung Kuo; Che-Chuan Wang
Journal:  BMC Neurosci       Date:  2021-09-14       Impact factor: 3.288
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.